Two Sigma Advisers’s Rocket Pharmaceuticals RCKT Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.65M Buy
+1,490,251
New +$3.65M 0.01% 857
2025
Q1
Sell
-10,845
Closed -$136K 2545
2024
Q4
$136K Sell
10,845
-5,200
-32% -$65.4K ﹤0.01% 2180
2024
Q3
$296K Sell
16,045
-12,800
-44% -$236K ﹤0.01% 1914
2024
Q2
$621K Sell
28,845
-48,731
-63% -$1.05M ﹤0.01% 1791
2024
Q1
$2.09M Sell
77,576
-33,000
-30% -$889K ﹤0.01% 1201
2023
Q4
$3.31M Sell
110,576
-75,175
-40% -$2.25M 0.01% 1019
2023
Q3
$3.81M Sell
185,751
-42,700
-19% -$875K 0.01% 873
2023
Q2
$4.54M Sell
228,451
-156,200
-41% -$3.1M 0.01% 818
2023
Q1
$6.59M Sell
384,651
-63,200
-14% -$1.08M 0.02% 695
2022
Q4
$8.76M Buy
447,851
+16,400
+4% +$321K 0.02% 557
2022
Q3
$6.89M Buy
431,451
+78,800
+22% +$1.26M 0.02% 611
2022
Q2
$4.85M Buy
352,651
+78,800
+29% +$1.08M 0.01% 789
2022
Q1
$4.34M Buy
273,851
+57,200
+26% +$907K 0.01% 856
2021
Q4
$4.73M Buy
216,651
+22,200
+11% +$485K 0.01% 792
2021
Q3
$5.81M Buy
194,451
+18,400
+10% +$550K 0.02% 715
2021
Q2
$7.8M Sell
176,051
-7,200
-4% -$319K 0.02% 658
2021
Q1
$8.13M Buy
183,251
+148,175
+422% +$6.57M 0.02% 649
2020
Q4
$1.92M Buy
35,076
+18,270
+109% +$1M 0.01% 1283
2020
Q3
$384K Buy
16,806
+2,100
+14% +$48K ﹤0.01% 1917
2020
Q2
$308K Buy
+14,706
New +$308K ﹤0.01% 2111
2018
Q4
Sell
-8,600
Closed -$212K 2436
2018
Q3
$212K Buy
+8,600
New +$212K ﹤0.01% 2068
2016
Q2
Sell
-9,575
Closed -$283K 2166
2016
Q1
$283K Sell
9,575
-6,275
-40% -$185K ﹤0.01% 1704
2015
Q4
$718K Sell
15,850
-4,100
-21% -$186K ﹤0.01% 1177
2015
Q3
$764K Buy
+19,950
New +$764K ﹤0.01% 1126